2. UroToday Home
  3. Video Lectures

Imaging: Prostate Cancer

Co-PSMA Trial Explores Tracer for Detecting Recurrence After Radical Prostatectomy - Louise Emmett
The Co-PSMA Trial: Comparing PSMA PET Tracers in Biochemically Recurrent Prostate Cancer - Louise Emmett
Balancing MRI Sensitivity and Specificity in Prostate Cancer Staging - Georgios Agrotis
PRIME Trial Compares Biparametric MRI to Multiparametric MRI for Prostate Cancer Diagnosis - Francesco Giganti & Andrei Purysko
Integrating PSMA PET Imaging: From Interpretation to Systemic Therapy Selection in Castration-Resistant Prostate Cancer - Oliver Sartor
Early-Phase Study Investigates Copper-61 PSMA PET for Prostate Cancer Imaging - Gary Ulaner
The Use of a Long-Axial PET Scanner for PSMA Imaging in Prostate Cancer - Rodney Hicks
Study Evaluates PSMA-PET-Based Nomograms for Prostate Cancer Prognosis - Kambiz Rahbar
Surgical Outcomes in High-Risk Prostate Cancer: PSMA-PET vs Conventional Imaging - Alessandro Viti
Online Platform Maps Theranostic Trials Worldwide for Patients and Physicians - Luke Nordquist
CLARIFY Trial: Multiday 64Cu-SAR-bisPSMA PET Scans Refine Prostate Cancer Assessment - Luke Nordquist
Response and Progression Criteria for PSMA PET: Imaging Prostate Cancer Outcomes - Wolfgang Fendler
PRINCE Trial Highlights Early Detection of Prostate Cancer Progression with PSMA PET-CT - Michael Hofman
Phase 3 CLARIFY Trial Investigates 64Cu-SAR-bisPSMA PET for Improved Prostate Cancer Detection - Louise Emmett
CLARIFY Trial: Advancing Prostate Cancer Imaging with 64Cu-SAR-bisPSMA PET - Neal Shore
PSMA PET in Prostate Cancer: Balancing Sensitivity and Clinical Relevance - Ravi Madan
COBRA Trial: Evaluating 64Cu-SAR-bisPSMA PET Imaging for Prostate Cancer Detection - Phillip Koo
Comparing PSMA Ligands for Prostate Cancer Imaging - Michael Hofman
COBRA Trial Shows Promise for 64Cu-SAR-bisPSMA PET in Biochemical Recurrence - Neal Shore
INDICATE Trial Seeks to Clarify Role of PET Scans in Prostate Cancer Recurrence - Neha Vapiwala
PSMA PET as a Biomarker for Advanced Prostate Cancer - Oliver Sartor
The 7th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer - Faina Shtern
PSMA PET's Influence on Prostate Cancer Studies - Jeremie Calais
The Push for PSMA-PET: Evaluating its Role in Prostate Cancer Diagnosis, Journal Club - Rashid Sayyid & Zachary Klaassen
Setting a Global Standard: Unveiling the New PSMA PET/CT Procedure Guideline - Wolfgang Fendler & Ken Herrmann
Tackling the Last Mile: A Major Component to Successfully Establish Radioligand Therapy - Ken Herrmann
Improving Appropriate Utilization of Imaging in Prostate Cancer Patients: A Discussion on the RADAR Articles - E. David Crawford
PYLARIFY PET Imaging: A Transformative Resource for Urologists and Radiologists - Michael Kipper
Unraveling Prostate Cancer Response: PSMA PET Sheds New Light on Treatment Effectiveness - Andrei Gafita & Wolfgang Fendler
PSMA PET Imaging in Clinical Practice - Thomas Hope & Jeremie Calais
PSMA PET Scan Imaging in Prostate Cancer - Ashley Ross
The Role of Imaging Before and After Diagnosis of Localized Prostate Cancer - Masoom Haider
Prostate Cancer and the Role of MRI, Molecular Imaging, and Their Integration - Peter Choyke
Smarter Screening In Prostate Cancer - Sigrid Carlsson
MRI and Active Surveillance for Prostate Cancer - Robert Reiter
Impact of Next Generation Imaging: What Is the Optimal (Current) Tracer for PET-Based Imaging for Staging Presentation - Ken Herrmann
First Standardized Framework Measuring PSMA PET/CT Response in Metastatic Castration‑Resistant Prostate Cancer - Wolfgang Fendler and Andrei Gafita
Future Perspectives in Prostate Imaging in Developing Countries - Ronaldo Hueb Baroni
Radiotherapy Guided by PSMA PET Molecular Imaging - Juan Galvis Serrano
Higher Rates of Metastatic Disease on PSMA PET for Biochemical Recurrence Risk Groups, Journal Club - Christopher Wallis & Zachary Klaassen
Results from the Phase 3 SPOTLIGHT Trial of 18F-rhPSMA-7.3 in Recurrent Prostate Cancer - David Schuster
The Impact of Imaging and Therapeutics Advances in Nonmetastatic Castration-Resistant Prostate Cancer - David Penson
Clinical Trial Equity in Radionuclide Treatment for Prostate Cancer - Joseph Osborne
PSMA PET/CT Imaging Indications in Prostate Cancer - Neal Shore & Oliver Sartor
NCCN Guidelines On PSMA Molecular Imaging - Tanya Dorff
Understanding Physiological PSMA Biodistribution - Jeremie Calais
The Use of Imaging for Patient Selection for PSMA Directed Therapies – Jeremie Calais
Developing a Theranostics Program, The Nebraska Cancer Specialists Model - Samuel Mehr
F-18-Labeled DCFPyL in Patients With Metastatic Prostate Cancer Undergoing Treatment With ADT – Esther Mena Gonzalez
PYLARIFY®, F 18-labeled PSMA Targeted PET Gains US FDA Approval - Michael Morris
PSMA Molecular Targeted Radiation Therapy - Andrei H. Iagaru
Bone Imaging in Metastatic Prostate Cancer: A Patient Education Video - Ephraim E. Parent
The Accidental Journey of Shepherding PSMA PET Imaging in Prostate Cancer to the Clinic in the United States - Thomas Hope
Improving Quality Imaging in Prostate Cancer with Gallium 68 PSMA-11 - Johannes Czernin
PSMA PET Imaging for Prostate Cancer Patient Education - Robert Flavell
The Impact on Patient Care and Clinical Outcomes Gallium 68 PSMA-11 in Suspected Prostate Cancer Metastasis - Jeremie Calais
68Ga-PSMA-11 PET approved in Biochemical Recurrent Prostate Cancer - Jeremie Calais
68Ga-PSMA-11 Joins FDA-Approved Tools for Management of Prostate Cancer - Thomas Hope
Limitations of PET Imaging in Prostate Cancer - Stefano Fanti
CONDOR: Study of 18F-DCFPyL PET/CT Imaging in Patients with Suspected Recurrence of Prostate Cancer - Michael J. Morris
68Ga-PSMA PET: A Novel Imaging Technique Prior to Radical Prostatectomy in Men with Intermediate or High Risk Prostate Cancer - Thomas Hope
PSMA PET/CT Imaging for Staging High-risk Prostate Cancer Prior to Curative-intent Surgery or Radiotherapy (proPSMA) - Michael Hofman and Declan Murphy
Integrating Advanced Molecular Imaging into Clinical Practice - Michael Morris
Advances in PSMA-directed Radionuclide Therapy - Howard Soule
The Use of Novel Imaging Methods in Prostate Cancer - Stefano Fanti
Insights on Nuclear Imaging for Prostate Cancer- Stefano Fanti
Incorporate Next Generation Imaging Tools Into Clinical Practice - Piet Ost
Advantages of PSMA PET in APC Imaging Presentation - Stefano Fanti
PSMA PET CT, A Mixed Blessing - Interview with Ian Davis
Imaging and Flare Responses When Assessing Patients with Metastatic Castration-Resistant Prostate Cancer - Anwar Padhani
The Future of Advanced Prostate Cancer Imaging Presentation - Stefano Fanti
Imaging Bone (Flare) Responses in Advanced Prostate Cancer Presentation - Anwar Padhani
Theranostic Approaches for Advanced Prostate Cancer - Michael Hofman
Diagnostic Imaging and Therapeutic Aspect of PSMA in Prostate Cancer by Michael Hofman
Axumin™ (Fluciclovine F 18) Injection for PET Imaging of Recurrent Prostate Cancer - Phillip Koo